Elamipretide
CAS 736992-21-5Protein
Overview
Elamipretide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL3833370).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Elamipretide expires 28 Feb 2034 and exclusivity 19 Sept 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2S)-6-amino-2-[[(2S)-2-[[(2R)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxy-2,6-dimethylphenyl)propanoyl]amino]-N-[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]hexanamide
- Canonical SMILES
- CC1=CC(=CC(=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N)NC(=O)[C@@H](CCCN=C(N)N)N)C)O
- InChIKey
- SFVLTCAESLKEHH-WKAQUBQDSA-N
Verified Supplier Partner
Do you supply Elamipretide? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.